PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways
Open Access
- 1 January 2016
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (1), 96-107
- https://doi.org/10.1158/0008-5472.can-15-0216
Abstract
Pancreatic ductal adenocarcinoma (PDAC) carries the most dismal prognosis of all solid tumors and is generally strongly resistant to currently available chemo- and/or radiotherapy regimens, including targeted molecular therapies. Therefore, unraveling the molecular mechanisms underlying the aggressive behavior of pancreatic cancer is a necessary prerequisite for the development of novel therapeutic approaches. We previously identified the protein placenta-specific 8 (PLAC8, onzin) in a genome-wide search for target genes associated with pancreatic tumor progression and demonstrated that PLAC8 is strongly ectopically expressed in advanced preneoplastic lesions and invasive human PDAC. However, the molecular function of PLAC8 remained unclear, and accumulating evidence suggested its role is highly dependent on cellular and physiologic context. Here, we demonstrate that in contrast to other cellular systems, PLAC8 protein localizes to the inner face of the plasma membrane in pancreatic cancer cells, where it interacts with specific membranous structures in a temporally and spatially stable manner. Inhibition of PLAC8 expression strongly inhibited pancreatic cancer cell growth by attenuating cell-cycle progression, which was associated with transcriptional and/or posttranslational modification of the central cell-cycle regulators CDKN1A, retinoblastoma protein, and cyclin D1 (CCND1), but did not impact autophagy. Moreover, Plac8 deficiency significantly inhibited tumor formation in genetically engineered mouse models of pancreatic cancer. Together, our findings establish PLAC8 as a central mediator of tumor progression in PDAC and as a promising candidate gene for diagnostic and therapeutic targeting. Cancer Res; 76(1); 1–12. ©2015 AACR.Other Versions
This publication has 36 references indexed in Scilit:
- Plac8 is required for White Adipocyte Differentiation in vitro and Cell Number Control in vivoPLOS ONE, 2012
- ONZIN deficiency attenuates contact hypersensitivity responses in miceImmunology & Cell Biology, 2012
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Differential expression analysis for sequence count dataGenome Biology, 2010
- Functional Depletion of Mahogunin by Cytosolically Exposed Prion Protein Contributes to NeurodegenerationCell, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ERThe Journal of cell biology, 2006
- The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase IMolecular and Cellular Biology, 2006
- Cellular Phenotyping of Secretory and Nuclear Prion Proteins Associated with Inherited Prion DiseasesOnline Journal of Public Health Informatics, 2002
- Systematic subcellular localization of novel proteins identified by large‐scale cDNA sequencingEMBO Reports, 2000